BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 22640807)

  • 1. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
    Maddur MS; Miossec P; Kaveri SV; Bayry J
    Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Th17 cells in autoimmune diseases.
    Yang J; Sundrud MS; Skepner J; Yamagata T
    Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
    Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
    Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
    Hu Y; Shen F; Crellin NK; Ouyang W
    Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y; Nakae S; Saijo S; Ishigame H
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
    Zhu S; Qian Y
    Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cells in autoimmune diseases.
    Han L; Yang J; Wang X; Li D; Lv L; Li B
    Front Med; 2015 Mar; 9(1):10-9. PubMed ID: 25652649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints.
    Miyamoto Y; Uga H; Tanaka S; Kadowaki M; Ikeda M; Saegusa J; Morinobu A; Kumagai S; Kurata H
    Mol Immunol; 2013 Jun; 54(2):199-207. PubMed ID: 23287598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells.
    Lexberg MH; Taubner A; Albrecht I; Lepenies I; Richter A; Kamradt T; Radbruch A; Chang HD
    Eur J Immunol; 2010 Nov; 40(11):3017-27. PubMed ID: 21061434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.
    Yamashita T; Iwakura T; Matsui K; Kawaguchi H; Obana M; Hayama A; Maeda M; Izumi Y; Komuro I; Ohsugi Y; Fujimoto M; Naka T; Kishimoto T; Nakayama H; Fujio Y
    Cardiovasc Res; 2011 Sep; 91(4):640-8. PubMed ID: 21622681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection.
    Akdis M; Palomares O; van de Veen W; van Splunter M; Akdis CA
    J Allergy Clin Immunol; 2012 Jun; 129(6):1438-49; quiz1450-1. PubMed ID: 22657405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease.
    Stephens GL; Swerdlow B; Benjamin E; Coyle AJ; Humbles A; Kolbeck R; Fung M
    Eur J Immunol; 2011 Apr; 41(4):952-62. PubMed ID: 21360526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
    Wang X; Ma C; Wu J; Zhu J
    J Neurosci Res; 2013 Jul; 91(7):871-81. PubMed ID: 23653308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Th17 cells and tumor microenvironment.
    Qi W; Huang X; Wang J
    Cell Immunol; 2013; 285(1-2):18-22. PubMed ID: 24044962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells.
    Yu RY; Gallagher G
    J Immunol; 2010 Dec; 185(12):7302-8. PubMed ID: 21076058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
    Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
    Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.